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Background: Home healthcare is one of the fastest growing sectors in the United States. Percutaneous injuries
from sharp medical devices (sharps) are a source of bloodborne pathogen infections among home healthcare
workers and community members. Sharps use and disposal practices in the home are highly variable and there is
no comprehensive analysis of the system of sharps procurement, use and disposal in home healthcare. This gap is
a barrier to effective public health interventions. The objectives of this study were to i) identify the full range of
pathways by which sharps enter and exit the home, stakeholders involved, and barriers for using sharps with injury
prevention features; and ii) assess the leverage points for preventive interventions.
Methods: This study employed qualitative research methods to develop two systems maps of the use of sharps
and prevention of sharps injuries in home healthcare. Twenty-six in-depth interview sessions were conducted
including home healthcare agency clinicians, public health practitioners, sharps device manufacturers, injury
prevention advocates, pharmacists and others. Interview transcripts were audio-recorded and analyzed
thematically using NVIVO qualitative research analysis software. Analysis of supporting archival material also was
conducted. All findings guided development of the two maps.
Results: Sharps enter the home via multiple complex pathways involving home healthcare providers and home users.
The providers reported using sharps with injury prevention features. However, home users’ sharps seldom had injury
prevention features and sharps were commonly re-used for convenience and cost-savings. Improperly discarded sharps
present hazards to caregivers, waste handlers, and community members. The most effective intervention potential
exists at the beginning of the sharps systems maps where interventions can eliminate or minimize sharps injuries, in
particular with needleless treatment methods and sharps with injury prevention features. Manufacturers and insurance
providers can improve safety with more affordable and accessible sharps with injury prevention features for home
users. Sharps disposal campaigns, free-of-charge disposal containers, and convenient disposal options remain essential.
Conclusions: Sharps injuries are preventable through public health actions that promote needleless treatment
methods, sharps with injury prevention features, and safe disposal practices. Communication about hazards regarding
sharps is needed for all home healthcare stakeholders.
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Home healthcare (HHC) services are a growing industry in
the United States. The U.S. Bureau of Labor Statistics pro-
jects “personal care aide” and “home care aide” to be the
2nd and 3rd fastest growing jobs during 2012–2022 [1]. In
2009, annual HHC expenditures were estimated at $72.2
billion [2], reflecting shorter hospital stays and more med-
ical technologies adapted for home settings [1,3]. Sharp
medical devices (collectively called “sharps”) including sy-
ringes with needles, infusion systems, lancets, and blood
collection devices have become common in HHC. As a re-
sult, workers face a risk of sharps injuries and bloodborne
pathogen (BBP) exposures, of which hepatitis B, hepatitis
C, and human immunodeficiency virus (HIV) are the most
concerning. Due to advancement in medical treatment and
technologies, people are living longer with chronic condi-
tions like HIV and hepatitis. Americans with HIV receive
care more frequently in the home setting than in other
health care settings [4].
A previous study by the research team found that ap-
proximately 35% of nurses and 6% of aides experienced at
least one injury with a previously used sharp during their
HHC career [5]. While caution needs to be exercised when
comparing studies due to differences in data collection and
analyses, the annual sharps injury incidence rate for home
care nurses (5.1 per 100 full-time equivalent (FTE) nurses)
[5] was consistent with the findings in hospitals and non-
hospital facilities [6-9]. Although home care agencies rou-
tinely train staff on hazards associated with BBP exposures
and exposure reporting protocols, difficulties exist in min-
imizing BBP hazards. Homes are more variable and less
controlled than facility-based settings [10,11] and educating
patients and families requires considerable resources and
expertise. When sharps injuries occur, a medical facility to
provide post-exposure care is not always nearby [11]. HHC
clinicians are covered by the Occupational Safety and
Health Administration’s (OSHA) Bloodborne Pathogens
Standard which requires the use of engineering and work
practice controls to eliminate or minimize BBP exposures
among employees [12]. Engineering controls include sharps
with injury prevention features (SIPFs), however, the previ-
ous study found that SIPFs were not frequently used in
home care [5].
The previous study also estimated a sharps injury inci-
dence rate for home care aides of 1.0 per 100 FTEs [5]. Al-
though this might appear low, with the substantial number
of aides in HHC, it translates to a large number of injuries.
Most aides’ injuries are associated with improperly disposed
sharps encountered during cleaning tasks [5]. Estimates sug-
gest that about 8–9 million Americans use sharps to manage
their health conditions at home, translating to more than 3
billion used sharps to be disposed of outside facility-based
health care settings annually [13]. In the United States, aides
employed by HHC agencies are supervised by a nurse andare not assigned medical procedures or tasks requiring
sharps use. However, focus group findings suggest that aides
are sometimes asked by a patient or family to assist with
medical procedures, such as using a lancet or injecting
medication – particularly if aides are hired directly by the
patient [10]. A study led by the University of Maryland
(USA) indicated that over a third of personal care assistants
who reported patient blood contact were using a lancet or
needle [14].
Objectives
The main objectives of this study were to: i) identify the
full range of pathways by which sharps enter and exit the
home, stakeholders involved, practices for use and dis-
posal, and barriers for using sharps with injury prevention
features; and ii) assess the leverage points for preventive
interventions. The study also summarized the analyses for
concise public health communication.
Methods
Study population and recruitment
A total of 26 in-depth interview sessions were conducted
between June 2011 and April 2013. The study employed
both purposive and snowball participant recruitment sam-
pling strategies through contacts with research partners
and other stakeholders. Two sessions included two inter-
viewees, thus, the total number of subjects interviewed was
28 (see Table 1). Nine sessions were conducted by phone
and the rest in-person.
Interview candidates were contacted by email and re-
ceived a recruitment message and one-page factsheet on
the interview process. The recruitment communication
indicated that the study needed interviewees who were
willing to share their experiences and opinions on one or
more of the following areas: i) various ways sharps enter
and exit the home; ii) stakeholders who are directly or in-
directly involved in sharps device procurement, use, and
disposal in the home; and iii) policies, programs, or other
initiatives that have either helped or hindered the routine
use of sharps with injury prevention features. Expertise
criteria for interview inclusion were as follows: nurses and
other practicing clinicians at leadership or supervisory
positions in HHC agencies; infection preventionists and
occupational safety and health (OSH) professionals who
can offer insights on BBP exposure prevention in HHC; or
other specialists who could provide valuable insights on
manufacturing, use, procurement, and/or disposal of
sharps in HHC. Four large HHC agencies in Massachu-
setts were targeted for interview recruitment and three
agreed to participate. At the planning stage, it was esti-
mated that 20 interview sessions comprising different
stakeholders could lead to theoretical saturation and this
was suitable within the initial budgeting and time planning
boundaries. Later on, the content analysis and suggestions
Table 1 Safe Home Care sharps study: interview sessions conducted during June 2011–April 2013
Interview
session #
Position/area of expertise Organization
1. Infection preventionist Private HHC agency A in Massachusetts (MA)
2. Safety and health officer Labor Union in MA
3. Safety and health officer Labor Union in MA
4. Education program coordinator Private HHC agency B in MA
5. Hospice clinical services coordinator Private HHC agency A in MA
6. IV therapy/clinical services coordinator Private HHC agency A in MA
7. Education program coordinator Private HHC agency C in MA
8. Clinical coordinator Private HHC agency C in MA
9. Pharmacist Pharmacy owner in a MA town/city
10. Physician, community outreach and prevention specialist Non-government organization (NGO) in MA
11. Diabetes awareness/ environmental health and safety services (2-person interview) NGO on environmental services outside MA
12. Sharps injury prevention specialist Independent specialist outside MA
13. Executive director Sharps manufacturer A outside MA
14. Chief executive officer Sharps manufacturer B outside MA
15. Clinical manager Sharps manufacturer C outside MA
16. Clinical specialist Sharps manufacturer C outside MA
17. Diabetes care manager/diabetes educator Healthcare organization in MA
18. Physician and founder of an NGO for sharps injury prevention Independent specialist outside MA
19. Diabetes educator Healthcare organization in MA
20. Founder of an NGO for sharps injury prevention Independent specialist outside MA
21. Director Sharps manufacturer D outside MA
22. Primary care physician Healthcare organization in MA
23. Health agent MA town/city
24. Occupational and environmental health consultant Independent specialist outside MA
25. Pharmacist/ academic pharmacy researcher University outside MA
26. Public health nurse manager & public health director (2-person interview) MA town/city
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more interview participants (e.g. diabetes educators, pub-
lic health officers and health agents, other HHC agency
representatives, and sharps’ manufacturers) than initially
planned to provide multiple perspectives for the overall
study findings.
Data collection
Interview scripts and protocols were approved by the Uni-
versity of Massachusetts Lowell’s Institutional Review Board.
Table 2 shows the major themes for which information was
gathered via the interview scripts. The interviews were no
longer than 60 minutes in duration. HHC agencies allowed
interviews during work hours and were compensated $40
per interviewee. Other interviewees were not compensated
if the interview was during their own work time and was
consistent with normal job responsibilities. Two research
team members conducted interviews in English. Each inter-
view participant provided signed informed consent.Data analyses
All 26 interview sessions were audio-recorded and
transcribed. Participants received their typed transcript
and had the opportunity to correct or clarify their re-
sponses. All 26 typed transcripts were coded paragraph-
by-paragraph with NVIVO Qualitative Research Software
(version 9.2) to obtain 3- to 4-level coding of themes
resulting in total almost 800 theme nodes. NVIVO
allowed weighing of themes depending on the number of
different interview sessions in which they were coded. A
qualitative research investigator with OSH expertise and a
nurse investigator coded the interviews. The final coding
structure comprised 12 first level parent theme nodes;
many parent themes were decided a priori based on the
questions asked in the scripts (Table 2). Most subthemes
under the parent nodes were emergent depending on the
interview transcript content. Interview findings were tri-
angulated between same and different stakeholders. Add-
itional triangulation was performed between the findings
Table 2 The main themes of Safe Home Care sharps
study for which qualitative data was collected via the
interview scripts
The first level of interview themes coded
● Participant occupation or expertise
● Recent or important events related to sharps injuries, BBP exposures
or preventive interventions
● Sharps injury prevention developments in HHC or general
● Sharps flow into the home
● Procurement of sharps by HHC agency
● Sharps exit homes – sharps disposal practices
● Insurance carriers coverage for sharps
● Physician’s influence on sharps choice
● Pharmacy’s role in sharps safety
● Re-use of sharps
● Participant advice to various stakeholders and needs assessment on
improving sharps safety
● Other information (subcoding for such sub-themes as sharps devices
and technology, agencies/organizations mentioned, medications re-
quiring sharps use, specific case descriptions, missed information
added by participant)
Markkanen et al. BMC Public Health  (2015) 15:359 Page 4 of 12of the present study and another study which the re-
search team was conducting simultaneously to investi-
gate a wide range of OSH hazards among home care
aides [10]. The OSH study included seven HHC
agencies different from those in this study and also
gathered information on sharps injuries and other blood
exposures.
An archival study was conducted to collect and review
both publicly available materials and internal docu-
ments pertaining to sharps procurement, reimburse-
ment, use, and disposal in the HHC setting. Archival
materials included book chapters, articles, training ma-
terials, HHC agency policies, photographs, and email
correspondence. These were also coded thematically
using NVIVO software.
Interview and archival study themes were integrated
and summarized in the form of maps to illustrate how
sharps enter and exit a home and the location of key
decision-makers relative to other stakeholders. The inte-
grated information then was analyzed using the “Hier-
archy of Controls,” to assess the key points in the sharps
systems that could be leveraged for effective interventions.
The Hierarchy of Controls is an established framework to
identify effective OSH/ public health interventions [15]; it
holds that the most effective intervention is complete
elimination of the hazard. The second most effective strat-
egy is substitution, followed by engineering controls and
administrative controls. Personal protective equipment
(PPE) is considered the least robust hazard control
method, however, sometimes PPE is the only available
method of protection (e.g., in healthcare).Results
Flow of sharps into the home
Figure 1 shows the flow of sharps into the home via the
different types of HHC providers; Figure 2 shows the
more complex situation of sharps flow into and of the
home for home users. In both figures, the background
shading in the form of a house indicates that only a por-
tion of the sharps system is contained in the home.
Most of the stakeholders and their contributions occur
outside of the home environment.
A HHC patient may receive sharps from both situations
simultaneously or sequentially. Sharps may enter the
home via agency or hospice clinicians (e.g., visiting nurse
or nurse practitioner), other medical service providers
(e.g., infusion therapy company) (Figure 1), or a patient or
family member may purchase sharps to address the pa-
tient’s needs (Figure 2). The route depends on the patient’s
medical treatment. For example, a visiting clinician may
provide sharps for an IV procedure. Alternatively, if a hos-
pice patient needs a subcutaneous pump for pain manage-
ment or medication, equipment may be ordered through a
hospice pharmacy and shipped to the home. Interviewees
noted that agencies and hospices are increasingly subcon-
tracting IV therapies to infusion companies or other med-
ical service providers.
Many patients self-administer injections for medical
treatments, such as for diabetes, multiple-sclerosis, and
blood clots. In these cases, patients or family members
typically buy prescribed medications and needed sharps
at pharmacies, specialty pharmacies, mail-order, or from
an unauthorized “black-market” source, including the
internet. Some medications are supplied in prefilled sy-
ringes (e.g., insulin or blood thinners) or in kits contain-
ing sharps and other supplies.
Use of sharps in the home
The HHC providers who were interviewed in this study,
reported that their agency clinicians used sharps with in-
jury prevention features (SIPFs). Agency representatives
shared challenges experienced by their clinicians using
SIPFs, in particular activating them; e.g., the sliding sheath
on a syringe did not properly engage and unexpectedly
slid back exposing the needle, or retractable syringes did
not retract because the plunger was not fully depressed.
Patient-procured devices generally do not have SIPFs.
Most interviewees reported that re-use of sharps by home
users for cost savings and convenience is common (Figure 2).
Re-use presents an occupational hazard for clinicians and
aides: unsecured sharps may be encountered unexpectedly
(e.g., in trash, bedding, chair cushions, on tables). A sharps
manufacturer cited testimonies from patients re-using insu-
lin syringes up to 20 times. A sharps safe disposal advocate
described re-use among home users (interview session #11,
Table 1):
Figure 1 Flow of sharps into the home via HHC agency, hospice or other medical service provider. The background shadowing in the form of a house
indicates which steps and stakeholders are located inside and outside the home environment. The HHC sharps system is much more extensive than the
home itself which contains only a portion of the system.
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mean, if you’re a diabetic and you’re on a budget and
you have to give yourself three or four shots a day,
they’ll use that same needle, most of these people don’t
see how that needle deteriorates every time you use it,
and don’t understand the chance of infection . . .
diabetes is an expensive disease.
A HHC agency educator explained the problem with
patients’ reusable lancet pens (session #7):And then something around these lancet pens. . .
it looks like an insulin pen, but it’s triggered with
a spring loaded device. And they’re nasty. Because
you’ve got to take the cap off. And then literally
with your fingers, you have to go in and pull out
this lancet. I mean, you could do it with tweezers.
You could do it with forceps if you had them. And
it’s tiny. . . But patients use [lancet pens] over and
over and over again. . . they save on the cost of
the lancets.
Figure 2 Flow of sharps into and out of the home for home users. The background shadowing in the form of a house indicates which steps and
stakeholders are located inside and outside the home environment. The HHC sharps system is much more extensive than the home itself which
contains only a portion of the system.
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patient and family member sharing a lancet – this lan-
cet had recently caused a sharp injury to an agencyemployee (session #1): “. . . the sharps injury happened
yesterday, it was in a different office. . . I think the
patient and the son are both using the [same] lancet“.
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HHC clinicians and service providers (e.g., infusion treat-
ment) normally carry disposal containers for their sharps,
which are returned to their organization for pickup by a
hazardous waste management company (Figure 1). If cli-
nicians use a patient’s sharp device, it typically goes into
the patient’s sharps disposal container. The HHC agency
infection preventionist described the significance of edu-
cating staff on using disposal containers correctly. The
agency’s containers were leak-proof when tightly capped
but some clinicians just placed the cap loosely, allowing
fluid leakage. She explained the importance of placing the
container upright in the clinician’s bag (interview session
#1): We have a side pouch that hangs off the clinician’s
bag and it zips and that keeps it upright and that's the
point of the sharps container. . . it has to be upright.
Options for patients or family to safely discard medical
sharps include community waste collection sites, sharps
return-by-mail boxes, or disposal kiosks. On rare occa-
sions, a pharmaceutical company provides a sharps dis-
posal container with their medication. Clinicians teach
patients to use a rigid puncture-resistant, opaque con-
tainer (e.g., laundry detergent bottle) for collecting and
disposing sharps. Patients are instructed to fill the con-
tainer not more than three-quarters full, cap it tightly
and tape the cap before throwing it into household
waste. Throughout the United States, many home users
and family members still throw used sharps into the
trash. Elderly residents have been seen bringing used
sharps in plastic bags to municipal waste collection sites.
Three interview sessions reported home users flushing
syringes down the toilet. A local public health officer
shared (session #21):
They have people flushing these down the toilet, and
they were ending up on the racks of the sewer plant. So
Wastewater Plant is willing to provide collection to try
to keep them out of the sewer system because it’s an
occupational hazard to their employees, because they
have bar racks that pick up things like hypodermic
needles like this and they have to actually break them
off and put them in bags . . .wastewater workers are
trying to keep the hypodermics out of the sewer.
Figure 2 illustrates home users’ sharps disposal prac-
tices. To prevent sharps injuries, most interviewees em-
phasized the importance of safe, convenient, and no-cost
sharps disposal options for home users. A sharps manu-
facturer expressed the following when asked for advice
on sharps injury prevention (session #14): “. . .the num-
ber one thing would be free sharps containers. . .and
number two would be a convenient drop-off and pick-up
for these sharps containers”. A drop-off station in every
town was considered important; a diabetes educatorexpressed empathy for a patient whose small town had
no sharps collection and who was unable to drive to the
nearest drop-off site.
Location of the most effective intervention points in the
sharps HHC systems map
Table 3 summarizes the priorities for public health inter-
ventions to prevent sharps injuries obtained by assessing
the systems maps and supporting data using the OSH
Hierarchy of Controls. Column 1 in Table 3 shows the
intervention levels in the hierarchy and column 2 shows
the location of the intervention level on the sharps sys-
tems maps (Figures 1 and 2). Column 3 gives specific ex-
amples of interventions that were identified from the
interview or archival data analysis, while column 4 gives
the frequency with which an intervention was cited in
the interviews and column 5 gives literature citations for
the interventions. The best way to improve overall
sharps safety in HHC is to eliminate the sharp, for ex-
ample by substituting it with an alternative treatment
that avoids the sharp entirely (elimination/substitution,
Table 3). This removes the sharp hazard completely and
impacts the largest number of people in the system. If a
sharp procedure cannot be eliminated, an effective pri-
mary prevention method is use of SIPFs (engineering
controls, Table 3). The study findings prioritize interven-
tions with stakeholders at the beginning of the systems
map where the potential for sharps injuries across the
entire HHC system can either be eliminated completely
or at least substantially reduced with SIPFs.
Sharps manufacturers and designers are best posi-
tioned to develop needleless instruments or SIPFs. Many
interviewees praised SIPFs. A HHC agency representa-
tive brought up that better standardization among SIPFs
would streamline training efforts and make sharps use
more consistent and intuitive as sharps from different
manufacturers function differently, each type requiring a
learning curve and focused attention when switching
from one to another. Other sharps safety stakeholders
include pharmaceutical companies, group purchasing or-
ganizations, physicians and other prescribing clinicians,
pharmacies/pharmacists, and insurance providers; of
these, pharmaceutical companies and health insurance
providers have the greatest injury prevention leverage.
Drug manufacturers are positioned to develop medical
treatments delivered without needles. Health insurers
control access to SIPFs for home users through their ap-
proved products and reimbursement policies.
The study interviewees advocated for robust sharps
disposal containers (an engineering control). Stake-
holders both at the beginning and middle of the maps
have the greatest leverage for injury prevention through
improving disposal approaches (Figures 1 and 2). Among
administrative controls, the roles of education and




Systems maps location of
stakeholders to intervene
(see Figures 1, 2)
Intervention examples cited both













- e.g. needleless IV-systems
● Apply needleless medication alternatives
- e.g. jet injectors, aerosols via inhalation, mucosal
vaccines tablets, transdermal patches
Engineering
controls





- e.g. existing retracting, sheathing, blunting
technologies
- e.g. new sharps innovations
● Design and use sharps disposal containers
Administrative
controls
Middle ● Promote and educate on safe use of sharps devices High
(60% or more)
[16,40-42]
● Promote and educate on safe sharps disposal
container use and community disposal practices
● Implement and annually review a BBP exposure
control plan
● Ensure work practices in line with an exposure
control plan
● Minimize re-use among home users when possible
Personal protective
equipment
Middle and end ● Use gloves/double-glove Moderate
(less than 50%)
[16,26,40-42]
●Use puncture resistant gloves
● Apply protective clothing
- Goggles, face shields, masks, gowns
- Other barriers/ filters
Sharps injury prevention methods, stakeholders’ location in the systems maps who can act at each method level, specific intervention examples, citation
frequency in study interviews, and examples of literature documentation.
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sharps device and disposal container use as well as insti-
tuting safe work or care practices. Personal protective
equipment (PPE) was cited least frequently as an avenue
for sharps injury prevention. Stakeholders at the end of
the maps have the highest injury risk resulting from
poor disposal practices and they can rely mostly on ad-
ministrative controls and PPE only (Figures 1 and 2).
Discussion
This study has highlighted the importance of interven-
tions at the beginning of the HHC sharps system
through eliminating/substituting sharps or with engin-
eering controls such as SIPFs and robust disposal con-
tainers. However, the study also supports that
engineering controls must go hand-in-hand with educa-
tion and standard precautions principles for effective
protection from BBP exposures. When triangulating
findings between different studies, the research team’s
large OSH home care aide study emphasized the import-
ance of teaching safety at new employee orientation –one supervisor of a large HHC agency stated that their
in-depth orientation training with an intensive BBP ex-
posure prevention component was viewed as a major
factor in curtailing the agency’s sharps injuries [10]. Lit-
erature also confirms the combination of preventive ap-
proaches for the best results; for example U.S. Centers
for Disease Control and Prevention’s (CDC) Workbook
for Designing, Implementing and Evaluating a Sharps In-
jury Prevention Program advocates multi-component
prevention approaches whereby elimination/substitution
and engineering controls are supported by education
and formation of needlestick prevention work groups in
HHC agencies [16].
Preventing sharps injuries at the beginning of the
systems: needleless treatment methods
Although eliminating and substituting sharps may sound
challenging, needleless treatment methods – such as jet
injectors, inhaled aerosols, and other needle-free methods –
are already on the market. A jet injector can deliver, via high
pressure, a prescribed drug, vaccine, or other medication
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addition to eliminating sharps injuries and hazardous
BBP waste, the literature has reported other jet injector
advantages. These include increased capacity for rapid
immunization of large populations, less technique sensi-
tivity for achieving different subcutaneous penetration
depths, elimination of plunger aspirations, and improved
tissue dispersions [17,18]. A clinical trial study on jet in-
jection of poliovaccine delivery among 400 infants in
Oman also measured parents’ preference on the delivery
method for the next vaccination. Among 185 parents who
responded 8 (4%) preferred needle-syringe vaccines, 172
(93%), preferred a needle-free method, and 5 (3%) had no
preference [19]. The disadvantage is cost: a 2013 source
reported a base price for a conventional needle injection
about 0.05 U.S. dollars versus 1 U.S. dollar for a needleless
jet injection [17]. However, this estimate excludes down-
stream costs: the total costs of an injection include sharps
waste and disposal costs as well. It is also important to re-
member that sharps injuries are costly and needle-free de-
vice prices decrease with greater demands. Mucosal
vaccinations, in particularly via oral and nasal routes, have
several advantages: easy to administer, natural route for
mucosal and systemic response, and possible cost-savings
due to lower dose needs for live vaccines [18]. Further-
more, aerosol therapies have developed over the years and
such treatment examples now comprise drug deliveries by
inhalation (e.g. oral inhalation of insulin), inhaled gene
therapy (e.g. treating cystic fibrosis), and vaccination by
inhalation (e.g. inhaled measles or flu vaccine) [20-23]. Fu-
ture studies will examine the success of these newer
therapies.
Importance of SIPFs and impact of public policy
If a sharp cannot be substituted with a needleless treatment
method, SIPFs are an essential primary prevention measure
against percutaneous injuries. As aforementioned, HHC
agencies are required by the OSHA’s Bloodborne Pathogens
Standard use engineering and work practice controls to
eliminate or minimize BBP exposures. SIPFs are an essen-
tial component of the engineering controls. Despite this
OSHA’s requirement, the earlier study found that SIPFs
were not frequently used [5].
The study findings emphasize that the most effective
sharps injury prevention exists at the beginning of the
systems map (Figures 1–2, Table 3), where both sharps
device and pharmaceutical manufacturers can eliminate
or drastically reduce sharps injury potential with needle-
less systems and SIPFs. Furthermore, both device manu-
facturers and insurance providers can improve safety
with more affordable and accessible SIPFs for home
users. Physicians typically specify sharps only in terms of
function for the prescribed medication, such as an insu-
lin syringe that makes the dose easy to read and measureaccurately. None of interviewees knew of a physician
specifying “safety device”; rather the prescription would
indicate, for example, “25-gauge subcutaneous 3 cc syr-
inge, or an insulin syringe.” Nonetheless, physicians are
important advocates to influence sharps manufacturers
and insurance companies for wider use of SIPFs among
home injectors. Physicians can also educate patients on
availability of SIPFs. The same pertains to pharmacies.
The Needlestick Safety and Prevention Act (NSPA) of
2000 that revised the OSHA’s BBP Standard has im-
proved sharps safety in hospital settings. In Massachu-
setts, a study analyzed trends in sharps injury rates
among employees of 76 acute care hospitals which had
reported 16,158 sharps injuries to the state surveillance
system during 2002 – 2007: within this time period, the
annual sharps injury rate had decreased by 22% and the
injury rates involving devices for which SIPFs were avail-
able and increasingly used had declined [24]. Another
study of sharps injury data from 85 hospitals estimated that
more than 100,000 sharps injuries were prevented every
year during 2001–2005 with a cost-saving of $69-415 mil-
lion [12]. Nonetheless, the NSPA impact is unclear for non-
hospital healthcare settings. The 2012 Consensus Statement
and Call to Action by U.S. organizations involved in sharps
injury prevention acknowledged that use of SIPFs in non-
hospital health care settings – i.e. HHC, long-term care,
practitioners offices and clinics – had been less consistent
[25]. The Statement addressed a critical need for obtaining
valid and reliable sharps injury data targeting non-hospitals.
One of the recommendations called for support from gov-
ernment agencies, such as OSHA, to promote regional em-
phasis programs on enforcement of the BBP standard and
CDC to support epidemiological research for non-hospital
settings. Accrediting and licensing organizations (e.g., the
Joint Commission) and workers’ compensation insurers can
influence healthcare worker safety by enhancing compli-
ance incentives. Furthermore, professional organizations
and product distributors can facilitate the flow of appropri-
ate devices and educational materials for non-hospital set-
tings [25]. Among others, the International Sharps Injury
Prevention Society provide comprehensive lists of SIPSs as
well as other products and tools to improve BBP exposure
prevention [26]. Recently, the World Health Organization
(WHO) released a global guideline on the use of safety-
engineered syringes for injections in healthcare settings [27].
Re-use of sharps
Re-use of medical sharps is widespread among home
users; the main reason is to save money. Convenience is
also a factor for patients requiring several injections a
day, and re-use may satisfy a desire to generate as little
non-biodegradable waste as possible [28]. Furthermore,
there are not good sharps disposal options available in
public and users do not want to carry many needles
Markkanen et al. BMC Public Health  (2015) 15:359 Page 10 of 12along. Little is known about health risks related to
sharps’ re-use; reports of adverse health outcomes are
rare. One research team studied lipohypertrophy – “a
thickened ‘rubbery’ swelling of tissue” – among 430 out-
patients injecting insulin; one risk factor was sharps re-
use, with risk increasing significantly when sharps were
used more than 5 times [29]. Some sources suggest there
can be needle tip damage due to re-use, however, one
study concluded that using insulin pens four to five
times a day does not affect the needle tip or increase
pain intensity [30]. It has also been reported that the
most important driver for medical product selection is
whether it is reimbursed by the country’s health service
system or insurance; for example, U.S. citizens and resi-
dents relying on Medicaid have the fewest choices in
medical technology [31]. Sharing of insulin pens is also a
concern. The U.S. CDC has issued an important clinical
reminder not to use multi-dose insulin pens for more than
one person even when the needle is changed because after
injection blood can flash back into the insulin cartridge,
thus, creating a bloodborne pathogen transmission risk if
the pen is used by more than one person [32].
Sharps disposal in communities
The study interviews showed that interventions to encour-
age safe sharps disposal policies and practices in commu-
nities remain a priority. The interviewees highlighted that
sharps disposed of unsafely in communities are a serious
occupational risk to waste management handlers. Sharps
are even flushed through the toilet. In addition to this
study, a survey conducted in New Jersey among 44 dia-
betic patients, 86% of respondents reported improper dis-
posal – 7% flushed sharps through the toilet [33].
There are no federal regulations or consensus standards
that direct consumers on how and where to dispose of
sharps; any disposal regulations are at the county or local
level [34]. The Environmental Protection Agency’s guide-
lines on disposal of medical sharps are too general for con-
sumers [35]. Similarly, no approved consumer guidelines
exist on how to choose a sharps disposal container, al-
though increasingly laundry detergent bottles have been
recommended if Food and Drug Administration (FDA)-ap-
proved sharps containers are not available [34]. In 1998, the
National Institute for Occupational Safety and Health pub-
lished guidelines on selecting sharps containers for the
workplace [36]. These guidelines provide comprehensive
directions on container selection, evaluation, and use; how-
ever, they are rather long and complex for consumers. A
similar, consumer-friendly tool could be developed that
would guide consumers on selection and proper use of
sharps containers. One of the interviewees (a sharps dis-
posal advocate) brought up the FDA’s role in incorporating
increased sharps disposal guidance into the existing drug
labeling requirements (interview session #12):You know, the FDA has to clear these drugs with
something called a 510 K pre-market notification
process. But why can’t they also require, alert the drug-
ging effort to provide a list of the community drop-off
centers or kickback programs or hey, call 1–800, US-
FDA and we’ll tell you based on your zip code where
your local drop-off point is.
At least two states – California (2008) and Massachusetts
(2012) – have banned sharps in household waste and
require special disposal [37,38]. As of July 2014, the
Massachusetts Department of Public Health listed 295
sharps disposal sites for Massachusetts and some of them
were funded by the Department of Public Health [39]. In
reality, disposal options are highly variable from one city or
town to another. Some pharmacies, hospitals, clinics, and
HIV programs may accept used needles and syringes. A rep-
resentative of a sharps manufacturer explained that the ma-
jority of corporate U.S. pharmacies are not very supportive
of their individual pharmacies taking back used sharps be-
cause of concerns about injury and possibility of litigation.
However, programs have been established—often in cooper-
ation with a municipality—for pharmacies to voluntarily
take sharps back. Another sharps manufacturer suggested
that pharmacies could become less resistant if a sharps dis-
posal program was based on a positive reward system. A
similar reward system principle could work for home users
(session #16): “You bring them back and we’ll reward you
with free needles or we’ll reward you with a point system that
gives them something in return for good compliance.”
Conclusions
This study developed two maps of the flow of sharps
into and out of home and the relative location of stake-
holders. The most effective intervention opportunities
are at the beginning of the map, where hazard elimin-
ation could be targeted: i) drug manufacturers by devel-
oping medical treatments with needleless methods; ii)
sharps manufactures by designing affordable needleless
instruments or SIPFs; and iii) health insurance providers
by providing devices affordably for home users through
their product listing and reimbursement policies. A par-
ticular challenge of intervening with these stakeholders
is that they are not at risk of sharps injuries and are not
directly impacted by the occurrence of sharps injuries.
The study findings show that the sharps system in HHC
is complex and that only a portion of the system is actually
located in the home environment. Therefore, comprehen-
sive public health interventions need to extend throughout
industry and the community. Interventions focused solely
on the home environment will not offer long-term effect-
iveness because they do not address the root cause – i.e.
the presence of a contaminated sharp. Nonetheless, inter-
ventions are needed in the home setting for safe sharps
Markkanen et al. BMC Public Health  (2015) 15:359 Page 11 of 12disposal practices and to minimize re-use among home-
users whenever possible. Training on sharps injury preven-
tion is needed for all stakeholders in systems of sharps use
in HHC. The figures and table developed here are intended
to assist with training development.
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